Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study


Yurdaydin C., Wedemeyer H., Caruntu F. A. , Curescu M. G. , YALÇIN K., AKARCA U. S. , ...More

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 56
  • City: Massachusetts
  • Country: United States Of America